黑白差异在子宫癌症状和诊断时的阶段
Xiao Xu1, Ling Chen2, Marcella Nunez-Smith3
1Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT, United States of America; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT, United States of America; Department of Obstetrics and Gynecology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States of America.
Gynecologic oncology
|December 13, 2023
概括
患有子宫癌的黑人患者更频繁地出现非绝经后出血 (PMB) 症状,这些症状与晚期诊断有关. 这些症状差异导致子宫癌分期的种族差异.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 健康差异 在健康上的差异
背景情况:
- 子宫癌的诊断和分期可能会受到患者人口统计学和症状呈现的影响.
- 癌症结局中的种族差异凸显了需要调查促成因素,如症状差异.
研究的目的:
- 为了调查子宫癌的症状是否在黑人和白人患者之间有所不同.
- 确定这些症状差异如何影响子宫癌诊断阶段.
主要方法:
- 利用监测,流行病学和最终结果-医疗保险数据库 (2008-2017) 对2328名黑人和21774名白人的子宫癌患者.
- 将预诊断症状分为单独的绝经后出血 (PMB),PMB与其他症状,单独的非PMB症状或没有症状.
- 通过回归模型分析了种族,症状表现和晚期诊断之间的关联.
主要成果:
- 与白人患者相比,黑人患者更经常出现PMB加其他症状 (63.1%对58.0%) 或单独非PMB症状 (13.1%对9.4%).
- 黑人患者有更高的未调整的晚期诊断风险 (45.0%vs30.3%).
- 症状的差异部分解释了晚期诊断的种族差异,非PMB症状与风险增加密切相关.
结论:
- 在诊断时,非绝经后出血症状与更先进的子宫癌阶段有关.
- 黑人患者中非PMB症状的更高患病率可能导致诊断延迟和晚期阶段化.
- 解决症状识别和评估差异对于改善黑人患者子宫癌结果至关重要.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195


